3 active not recruiting. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Active not recruiting 3 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Intervertebral Disc Degeneration: new trials by email Literature Review of Intervertebral Disc Degeneration trials Research Report on Intervertebral Disc Degeneration
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back Pain Rexlemestrocel-L + HA mixture, Saline - Degenerative Disc Disease | Phase 3 | Active not recruiting | Mesoblast, Ltd. | 300 | 2024-07-03 | 2026-06-17 |
| Moderate - Severe Degenerative Disc Disease Evaluation of the Lumbar Spine SB-01 For Injection, Sham Needle - Lumbar Degenerative Disc Disease | Phase 3 | Active not recruiting | Spine BioPharma, Inc | 417 | 2022-08-19 | 2025-06-10 |
| Efficacy of Intradiscal Injection of BM-MSC in Subjects With Chronic Low Back Pain (LBP) Due to Lumbar Degenerative Disc Disease (DDD) Unresponsive Allogenic BM-MSCs Injection, Sham Procedure - Recurrent Low Back Pain, Degenerative Disc Disease (DDD) | Phase 2 / Phase 3 | Active not recruiting | University Hospital, Montpellier | 113 | 2019-02-18 | 2025-09-30 |
Low Back Pain (1)
Bone Diseases (3) · Musculoskeletal Diseases (3) · Spinal Diseases (3) · Back Pain (1) · Neurologic Manifestations (1) · Pain (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Injections (1) · Lidocaine (1) · Sodium Chloride (1)
Mesoblast, Ltd. (1) · Spine BioPharma, Inc (1) · University Hospital, Montpellier (1)
United States (2) · France (1) · Germany (1) · Italy (1) · Spain (1)
Christopher Gilligan, MD, MBA (1) · Roger D Brown (1)
2017 (1)